2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors
about
The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic DiseasesHuman monocytes respond to extracellular cAMP through A2A and A2B adenosine receptorsA novel adenosine precursor 2',3'-cyclic adenosine monophosphate inhibits formation of post-surgical adhesionsThe 2',3'-cAMP-adenosine pathwayThe brain in vivo expresses the 2',3'-cAMP-adenosine pathway.Extracellular 2',3'-cAMP and 3',5'-cAMP stimulate proliferation of preglomerular vascular endothelial cells and renal epithelial cellsExtracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cellsPurines: forgotten mediators in traumatic brain injury.In vivo cardiovascular pharmacology of 2',3'-cAMP, 2'-AMP, and 3'-AMP in the ratP2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.Regulation of Cell Proliferation by the Guanosine-Adenosine Mechanism: Role of Adenosine ReceptorsAntiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension.On the G protein-coupling selectivity of the native A2B adenosine receptor.Discovery and Roles of 2',3'-cAMP in Biological Systems.
P2860
Q28080657-4F7AC105-2B14-4239-BFEC-CAB6F74E43BEQ33750869-25C3B4A5-7823-442E-8130-8823C74BBBBCQ34100615-AE4DCDF8-ACFA-4895-8BF1-A34E8437459FQ35601599-2285F6B5-37A0-4493-A73D-A3AC2054C1B4Q36020573-754A0151-F2CA-414A-89B9-0912ECEAB8C0Q36312688-5CDDCFB1-4785-46B3-B25E-E62D7A0922D0Q36527859-38D6A131-CBD9-4766-AFDC-0C3E5FF18726Q36788533-8C7BCA01-AD94-4312-8237-6764A0DBFCCDQ37027031-C9C65868-FB22-4EA8-963E-1E03EFA9772FQ37468664-16209369-E95B-45BA-88A6-9048DAF95470Q37720630-31DDDF25-90A5-4B4A-AA13-98F18102F264Q41924569-517AE8B5-3367-4051-8FE3-215E897C4B5EQ41989216-19A9A817-11E7-48CD-BDF2-AA2A726B28E7Q47130813-8CF238BE-49AD-496E-8459-47E66A3D0772Q47310583-BB707AB6-E0C3-42C9-A468-EC0DC1BDBF08Q49065611-214BA55E-3172-4814-9155-1646715E6DA2
P2860
2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
2',3'-cAMP, 3'-AMP, and 2'-AMP ...... roliferation via A2B receptors
@ast
2',3'-cAMP, 3'-AMP, and 2'-AMP ...... roliferation via A2B receptors
@en
type
label
2',3'-cAMP, 3'-AMP, and 2'-AMP ...... roliferation via A2B receptors
@ast
2',3'-cAMP, 3'-AMP, and 2'-AMP ...... roliferation via A2B receptors
@en
prefLabel
2',3'-cAMP, 3'-AMP, and 2'-AMP ...... roliferation via A2B receptors
@ast
2',3'-cAMP, 3'-AMP, and 2'-AMP ...... roliferation via A2B receptors
@en
P2093
P2860
P1476
2',3'-cAMP, 3'-AMP, and 2'-AMP ...... roliferation via A2B receptors
@en
P2093
Delbert G Gillespie
Edwin K Jackson
P2860
P304
P356
10.1152/AJPHEART.00336.2011
P577
2011-05-27T00:00:00Z